• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞周期蛋白D和细胞周期蛋白E在正常及腺瘤性垂体中的表达

Cyclin D and cyclin E expression in normal and adenomatous pituitary.

作者信息

Jordan S, Lidhar K, Korbonits M, Lowe D G, Grossman A B

机构信息

Department of Histopathology, St Bartholomew's Hospital, London EC1A 7BE, UK.

出版信息

Eur J Endocrinol. 2000 Jul;143(1):R1-6. doi: 10.1530/eje.0.143r001.

DOI:10.1530/eje.0.143r001
PMID:10870044
Abstract

OBJECTIVES

Cyclins play an important role in the regulation of cell progression through the cell cycle. Over-expression of the cyclins has been shown in many different tumour types. Pituitary adenomas are a common form of endocrine neoplasia in the human, but have been little studied in terms of the expression of the principal cyclins regulating checkpoint exit, cyclin D1 and cyclin E.

METHODS

We therefore investigated the expression of cyclin D1 and cyclin E in a range of benign and metastatic pituitary tumours. We studied a total of 95 pituitaries, including normal pituitary (n=20), Cushing's disease (n=19), somatotroph tumours (n=19), non-functioning adenomas (n=18), prolactinomas (n=7), aggressive tumours (n=9) and pituitary carcinoma (n=3). All tumours and normal tissue were immunostained for cyclin D1 and cyclin E using a standard technique, and were then subjected to blinded analysis by a single observer and the extent of staining quantified on the basis of 500 cell counts per tissue. The distribution of positive staining between different tissues was analysed by non-parametric test procedures.

RESULTS

There was no cytoplasmic staining for cyclin D1 in any tissue. Nuclear staining was generally sparse, but was statistically more frequent in non-functioning and aggressive tumours compared with other tumour types or normal pituitary. Cyclin E was also sparsely expressed, but was specifically increased in corticotroph tumours from patients with Cushing's disease.

CONCLUSIONS

We report cyclin D1 over-expression in aggressive and non-functioning pituitary tumours, and that cyclin E expression is more frequently seen in Cushing's disease. The high level of cyclin E expression in Cushing's disease may relate to the low level of p27 protein expression previously reported in corticotroph tumours.

摘要

目的

细胞周期蛋白在调控细胞通过细胞周期进程中发挥重要作用。在许多不同类型肿瘤中均已发现细胞周期蛋白的过表达。垂体腺瘤是人类内分泌肿瘤的常见形式,但在调控关卡退出的主要细胞周期蛋白(细胞周期蛋白D1和细胞周期蛋白E)的表达方面研究较少。

方法

因此,我们研究了细胞周期蛋白D1和细胞周期蛋白E在一系列良性和转移性垂体肿瘤中的表达。我们共研究了95个垂体,包括正常垂体(n = 20)、库欣病(n = 19)、生长激素瘤(n = 19)、无功能腺瘤(n = 18)、催乳素瘤(n = 7)、侵袭性肿瘤(n = 9)和垂体癌(n = 3)。使用标准技术对所有肿瘤和正常组织进行细胞周期蛋白D1和细胞周期蛋白E免疫染色,然后由一名观察者进行盲法分析,并根据每个组织500个细胞计数对染色程度进行量化。通过非参数检验程序分析不同组织之间阳性染色的分布情况。

结果

在任何组织中均未发现细胞周期蛋白D1的细胞质染色。核染色通常稀疏,但与其他肿瘤类型或正常垂体相比,在无功能和侵袭性肿瘤中在统计学上更常见。细胞周期蛋白E也表达稀疏,但在库欣病患者的促肾上腺皮质激素细胞肿瘤中特异性增加。

结论

我们报告了侵袭性和无功能垂体肿瘤中细胞周期蛋白D1的过表达,并且细胞周期蛋白E的表达在库欣病中更常见。库欣病中细胞周期蛋白E的高表达水平可能与先前报道的促肾上腺皮质激素细胞肿瘤中p27蛋白表达水平低有关。

相似文献

1
Cyclin D and cyclin E expression in normal and adenomatous pituitary.细胞周期蛋白D和细胞周期蛋白E在正常及腺瘤性垂体中的表达
Eur J Endocrinol. 2000 Jul;143(1):R1-6. doi: 10.1530/eje.0.143r001.
2
Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland.垂体腺瘤和正常垂体组织中细胞周期蛋白的表达分析。
Clin Endocrinol (Oxf). 2000 Sep;53(3):337-44. doi: 10.1046/j.1365-2265.2000.01088.x.
3
Galanin in human pituitary adenomas: frequency and clinical significance.甘丙肽在人垂体腺瘤中的表达:发生率及临床意义
Clin Endocrinol (Oxf). 2002 Mar;56(3):397-403. doi: 10.1046/j.1365-2265.2002.01486.x.
4
Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.细胞周期抑制剂p27Kip1在正常促肾上腺皮质激素细胞、促肾上腺皮质激素肿瘤及恶性垂体肿瘤中低表达。
J Clin Endocrinol Metab. 1999 Oct;84(10):3823-30. doi: 10.1210/jcem.84.10.6066.
5
Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.促肾上腺皮质激素分泌肿瘤中p27/kip1基因的突变与表达分析
Oncogene. 1998 Jan 8;16(1):69-76. doi: 10.1038/sj.onc.1201516.
6
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.人生长激素瘤中生长激素和1型胰岛素样生长因子受体的表达降低以及生长激素受体可能突变的分析
Clin Endocrinol (Oxf). 2003 Sep;59(3):328-38. doi: 10.1046/j.1365-2265.2003.01851.x.
7
Differential expression of cyclin D1 in human pituitary tumors: relation to MIB-1 and p27/Kip1 labeling indices.细胞周期蛋白D1在人垂体肿瘤中的差异表达:与MIB-1和p27/Kip1标记指数的关系。
J Egypt Natl Canc Inst. 2011 Dec;23(4):171-9. doi: 10.1016/j.jnci.2011.11.003. Epub 2011 Dec 29.
8
Cell cycle dysregulation in pituitary oncogenesis.垂体肿瘤发生中的细胞周期失调。
Front Horm Res. 2004;32:34-62. doi: 10.1159/000079037.
9
Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?库欣病患者生长激素和催乳素对促肾上腺皮质激素释放激素的反应:腺瘤性促肾上腺皮质细胞的旁分泌作用?
Clin Endocrinol (Oxf). 1998 Oct;49(4):433-9. doi: 10.1046/j.1365-2265.1998.00531.x.
10
Human TRH receptor messenger ribonucleic acid levels in normal and adenomatous pituitary: analysis by the competitive reverse transcription polymerase chain reaction method.正常及腺瘤性垂体中人类促甲状腺激素释放激素受体信使核糖核酸水平:采用竞争性逆转录聚合酶链反应法进行分析
Clin Endocrinol (Oxf). 1995 Mar;42(3):243-8. doi: 10.1111/j.1365-2265.1995.tb01871.x.

引用本文的文献

1
The Roles of PD-L1, Ki-67, P53, and Cyclin D1 in PitNETs: Diagnostic and Prognostic Implications in a Series of 74 Patients.PD-L1、Ki-67、P53和细胞周期蛋白D1在垂体神经内分泌肿瘤中的作用:74例患者的诊断和预后意义
Int J Mol Sci. 2025 Aug 13;26(16):7830. doi: 10.3390/ijms26167830.
2
Epigenetic implications in the pathogenesis of corticotroph tumors.表观遗传学在促肾上腺皮质激素细胞肿瘤发病机制中的意义
Pituitary. 2025 Apr 21;28(3):51. doi: 10.1007/s11102-025-01522-3.
3
New insights in cellular senescence: The pituitary model.细胞衰老的新见解:垂体模型。
J Neuroendocrinol. 2025 May;37(5):e70008. doi: 10.1111/jne.70008. Epub 2025 Mar 3.
4
Cushing syndrome.库欣综合征
Nat Rev Dis Primers. 2025 Jan 23;11(1):4. doi: 10.1038/s41572-024-00588-w.
5
Seliciclib: A New Treatment for Cushing's Disease?塞利西利布:库欣病的一种新疗法?
touchREV Endocrinol. 2024 Apr;20(1):3-4. doi: 10.17925/EE.2023.20.1.4. Epub 2023 Nov 8.
6
Current and Emerging Pharmacological Therapies for Cushing's Disease.库欣病的现有和新兴药物治疗方法。
Curr Pharm Des. 2024;30(10):757-777. doi: 10.2174/0113816128290025240216110928.
7
Clinical and Molecular Characteristics of Gonadotroph Pituitary Tumors According to the WHO Classification.根据世界卫生组织分类的促性腺垂体肿瘤的临床和分子特征。
Endocr Pathol. 2024 Mar;35(1):1-13. doi: 10.1007/s12022-023-09794-w. Epub 2023 Dec 14.
8
Pituitary Tumors: Molecular Insights, Diagnosis, and Targeted Therapy.垂体肿瘤:分子见解、诊断与靶向治疗
Cancers (Basel). 2023 Nov 22;15(23):5526. doi: 10.3390/cancers15235526.
9
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.神经调节素 B 受体作为促肾上腺皮质腺瘤的潜在治疗靶点。
Pituitary. 2023 Oct;26(5):597-610. doi: 10.1007/s11102-023-01350-3. Epub 2023 Aug 29.
10
Advances in Molecular Pathophysiology and Targeted Therapy for Cushing's Disease.库欣病的分子病理生理学进展与靶向治疗
Cancers (Basel). 2023 Jan 13;15(2):496. doi: 10.3390/cancers15020496.